We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA recently posted three separate warning letters to its website citing a sponsor, an investigator and an institutional review board (IRB) for a range of violations.